Current use for old antibacterial agents: polymyxins, rifampin, and aminoglycosides

被引:13
作者
Kaye, D [1 ]
机构
[1] Drexel Univ, Coll Med, Dept Med, Philadelphia, PA 19129 USA
关键词
D O I
10.1016/j.idc.2004.04.007
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
This article discusses three classes of antibacterial agents that are uncommonly used in bacterial infections (other than mycobacterial infections) and can be thought of as special-use agents. These are the polymyxins, rifampin, and the aminoglycosides.
引用
收藏
页码:669 / +
页数:22
相关论文
共 107 条
[1]   QUINOLONES IN TREATMENT OF HUMAN BRUCELLOSIS - COMPARATIVE TRIAL OF OFLOXACIN-RIFAMPIN VERSUS DOXYCYCLINE-RIFAMPIN [J].
AKOVA, M ;
UZUN, O ;
AKALIN, HE ;
HAYRAN, M ;
UNAL, S ;
GUR, D .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1993, 37 (09) :1831-1834
[2]   A meta-analysis of the relative efficacy and toxicity of single daily dosing versus multiple daily dosing of aminoglycosides [J].
Ali, MZ ;
Goetz, MB .
CLINICAL INFECTIOUS DISEASES, 1997, 24 (05) :796-809
[3]   TREATMENT OF HUMAN BRUCELLOSIS WITH DOXYCYCLINE PLUS RIFAMPIN OR DOXYCYCLINE PLUS STREPTOMYCIN - A RANDOMIZED, DOUBLE-BLIND-STUDY [J].
ARIZA, J ;
GUDIOL, F ;
PALLARES, R ;
VILADRICH, PF ;
RUFI, G ;
CORREDOIRA, J ;
MIRAVITLLES, MR .
ANNALS OF INTERNAL MEDICINE, 1992, 117 (01) :25-30
[4]   Aminoglycoside-associated nephrotoxicity in the elderly [J].
Baciewicz, AM ;
Sokos, DR ;
Cowan, RI .
ANNALS OF PHARMACOTHERAPY, 2003, 37 (02) :182-186
[5]   A meta-analysis of extended-interval dosing versus multiple daily dosing of aminoglycosides [J].
Bailey, TC ;
Little, JR ;
Littenberg, B ;
Reichley, RM ;
Dunagan, WC .
CLINICAL INFECTIOUS DISEASES, 1997, 24 (05) :786-795
[6]   The treatment of respiratory pseudomonas infection in cystic fibrosis - What drug and which way? [J].
Banerjee, D ;
Stableforth, D .
DRUGS, 2000, 60 (05) :1053-1064
[7]   EXPERIENCE OF ONCE-DAILY AMINOGLYCOSIDE DOSING USING A TARGET AREA UNDER THE CONCENTRATION-TIME CURVE [J].
BARCLAY, ML ;
DUFFULL, SB ;
BEGG, EJ ;
BUTTIMORE, RC .
AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 1995, 25 (03) :230-235
[8]   Aminoglycoside adaptive resistance - Importance for effective dosage regimens [J].
Barclay, ML ;
Begg, EJ .
DRUGS, 2001, 61 (06) :713-721
[9]  
Barza M, 1996, BRIT MED J, V312, P338
[10]  
Beausoleil HE, 2001, RECEPTOR CHANNEL, V7, P401